 ALACHUA, Fla., Feb. 22, 2021 GLOBE NEWSWIRE -- Axogen, Inc. NASDAQ: AXGN, a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2020. 